| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1091692288 |
| P356 | DOI | 10.1186/S12929-017-0382-4 |
| P932 | PMC publication ID | 5598036 |
| P698 | PubMed publication ID | 28911329 |
| P50 | author | Maria Joao Paiva-Lopes | Q90707720 |
| P2093 | author name string | José Delgado Alves | |
| P2860 | cites work | Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders | Q26747482 |
| Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology | Q26827400 | ||
| New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism | Q26851804 | ||
| Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis | Q85408859 | ||
| Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. | Q46783416 | ||
| Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. | Q51366532 | ||
| Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome. | Q51370354 | ||
| Serum lipid level in Iranian patients with psoriasis. | Q51469568 | ||
| HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. | Q52628286 | ||
| Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study | Q57260288 | ||
| Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus | Q60709702 | ||
| Prevalence of cardiovascular risk factors in patients with psoriasis | Q60711908 | ||
| Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis | Q81782913 | ||
| Psoriasis is associated with lipid abnormalities at the onset of skin disease | Q82875363 | ||
| Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1 | Q84595346 | ||
| Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein | Q85347658 | ||
| Global epidemiology of psoriasis: a systematic review of incidence and prevalence | Q26991871 | ||
| Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis | Q27007133 | ||
| Psoriasis and comorbid diseases: Epidemiology | Q30235889 | ||
| Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms | Q30250110 | ||
| ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions | Q30432802 | ||
| Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. | Q34253312 | ||
| Anti-psoriatic therapy recovers high-density lipoprotein composition and function | Q34259215 | ||
| Cross-talk between apolipoprotein E and cytokines | Q35104765 | ||
| ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium | Q35744441 | ||
| Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom | Q35753936 | ||
| Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis | Q35762924 | ||
| Antiinflammatory properties of HDL. | Q35919164 | ||
| The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties | Q35994365 | ||
| Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile. | Q36514727 | ||
| Psoriasis alters HDL composition and cholesterol efflux capacity | Q36520321 | ||
| Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function | Q36681220 | ||
| Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis | Q36957991 | ||
| Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis | Q36993064 | ||
| High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction | Q37593287 | ||
| Lipid disturbances in psoriasis: an update. | Q37779736 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| Inflammation alters HDL composition and function: implications for HDL-raising therapies | Q38068018 | ||
| Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis. | Q38118351 | ||
| Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges | Q38135797 | ||
| HDL in innate and adaptive immunity. | Q38220759 | ||
| Dysfunctional HDL and atherosclerotic cardiovascular disease | Q38577283 | ||
| The Inflammatory Response in Psoriasis: a Comprehensive Review | Q38792930 | ||
| Psoriasis and autoimmunity | Q38957672 | ||
| Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. | Q39087357 | ||
| Psoriasis as a human model of disease to study inflammatory atherogenesis | Q39160397 | ||
| Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function. | Q39664151 | ||
| Should antibodies to high-density lipoprotein cholesterol and its components be measured in all systemic lupus erythematosus patients to predict risk of atherosclerosis? | Q43174077 | ||
| Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis | Q43545547 | ||
| Apolipoprotein E and atherosclerosis: beyond lipid effect | Q45244818 | ||
| Serum lipid profile paraoxonase and arylesterase activities in psoriasis | Q46069640 | ||
| Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES). | Q46386834 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psoriasis | Q179945 |
| cardiovascular disease | Q389735 | ||
| high-density lipoprotein | Q410020 | ||
| lipid metabolism | Q2792936 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 73 | |
| P577 | publication date | 2017-09-14 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Psoriasis-associated vascular disease: the role of HDL. | |
| P478 | volume | 24 |
Search more.